Denosumab as add-on to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer. Presented at SABCS.
Mehr ...A meta-analysis of individual patient data from 12 randomized trials including 15,457 patients. Presented as SABCS 2019.
Mehr ...MammaMia! Patientenkongress Gynäkologische Krebserkrankungen am 2. Februar in Frankfurt.
Mehr ...Die Anmeldung zum AGO-Mamma State of the Art Meeting 2020 am 29. Februar ist ab sofort möglich.
Mehr ...GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd